SCHEMBL891414

SCHEMBL891414

CCc1c[nH]c(CC)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL28065643 0.84 TP53 (0.37)
SCHEMBL28306543 0.83 MPO (0.34)
SCHEMBL891014 0.80 GABRA1 (0.33)
SCHEMBL12461863 0.80 DAO (0.37)
SCHEMBL28199411 0.77
SCHEMBL27926108 0.77 ALDH1A1 (0.40)
SCHEMBL5804646 0.76
SCHEMBL16016412 0.74 LMNA (0.43)
SCHEMBL20208260 0.74 DAO (0.41)
SCHEMBL25422518 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2790828-B1 PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL CO LP (US) 2018-09-19 EP claimed
US-9956548-B2 Preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-05-01 US claimed
CN-104105545-B preparation of olefin oligomerization catalyst 切弗朗菲利浦化学公司 2017-07-04 CN claimed
CN-104361997-A DSC battery manufacturing electrolyte solution UNIV ZHEJIANG SCIENCE & TECH 2015-02-18 CN claimed
EP-2790828-A1 PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST Chevron Phillips Chemical Company LP (US) 2014-10-22 EP claimed
CN-104105545-A Preparation of olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL COMOANY LP 2014-10-15 CN claimed
WO-2013089962-A1 PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-06-20 WO claimed
US-20130150642-A1 Preparation of an Olefin Oligomerization Catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-06-13 US claimed
US-8362278-B2 Methods for the conversion of a substituted furan to a substituted pyrrole CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-01-29 US claimed
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-04-05 US claimed
US-20260061408-A1 CATALYST COMPOSITION FOR OLEFIN OLIGOMERIZATION INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2026-03-05 US disclosed
US-12162829-B2 Gas phase process for acrylate production from ethylene and carbon dioxide CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2024-12-10 US disclosed
EP-3634932-B1 HIGH POROSITY AROMATIC RESINS AS PROMOTERS IN ACRYLATE PRODUCTION FROM COUPLING REACTIONS OF OLEFINS AND CARBON DIOXIDE CHEVRON PHILLIPS CHEMICAL CO LP (US) 2024-07-24 EP disclosed
EP-2912076-B1 NOVEL CATALYST COMPOSITIONS AND METHOD OF MAKING AND USING THE SAME FOR THE POLYMERIZSATION OF OLEFIN. HIGH DENSITY POLYETHYLENE CHEVRON PHILLIPS CHEMICAL CO LP (US) 2024-05-15 EP disclosed
EP-4359382-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS Chevron Phillips Chemical Company LP (US) 2024-05-01 EP disclosed
US-6147106-A USEFUL FOR THE TREATMENT OF DISEASES RELATED TO UNREGULATED PROTEIN KINASE SIGNAL TRANSDUCTION, INCLUDING CELL PROLIFERATIVE DISEASES SUCH AS CANCER, ATHEROSCLEROSIS, ARTHRITIS AND RESTENOSIS AND METABOLIC DISEASES SUCH AS SUGEN, INC. (US) 2000-11-14 US disclosed
WO-1999048868-A9 HETEROCYCLIC CLASSES OF COMPOUNDS FOR THE MODULATING TYROSINE PROTEIN KINASE SUGEN INC (US) 2000-04-20 WO disclosed
WO-1999048868-A2 HETEROCYCLIC CLASSES OF COMPOUNDS FOR THE MODULATING TYROSINE PROTEIN KINASE SUGEN, INC. (US) 1999-09-30 WO disclosed
EP-0929520-A1 INDOLINONE COMBINATORIAL LIBRARIES AND RELATED PRODUCTS AND METHODS FOR THE TREATMENT OF DISEASE Sugen, Inc. (US) 1999-07-21 EP disclosed
WO-1998007695-A1 INDOLINONE COMBINATORIAL LIBRARIES AND RELATED PRODUCTS AND METHODS FOR THE TREATMENT OF DISEASE SUGEN, INC. (US) 1998-02-26 WO disclosed